Schedule 13G ownership disclosure

ELEDON PHARMACEUTICALS INC COM

Common Stock, par value $0.001 per share · CUSIP: 28617K101

Event date: 2025-11-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 4,203,764.00 · Class: 5.28%

  • Coastlands Capital Partners LP

    Shares: 4,203,764.00 · Class: 5.28%

  • Coastlands Capital GP LLC

    Shares: 4,203,764.00 · Class: 5.28%

  • Coastlands Capital LLC

    Shares: 4,203,764.00 · Class: 5.28%

  • Matthew D. Perry

    Shares: 4,762,691.00 · Class: 5.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-115374
Form type
SCHEDULE 13G
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Nov 24, 2025
Reporting period
Nov 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub